[Retinal lesions in HIV seropositive patients] NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Retinal lesions in HIV seropositive patients]

J Fr Ophtalmol. 1989;12(8-9):521-4. Unique Identifier : AIDSLINE MED/90244046
Gabrieli CB; Angarano G; Moramarco A; Locaputo S; Rasi V; Pacella E; Chaire d'Optique physiopathologique, Universite de Bari, Italie.

Abstract: 118 patients with HIV infection underwent complete ophthalmologic examination to detect the presence of any eye pathology. The study was intended to show a correlation between such pathology and the total CD4 + lymphocyte count considered to be indicative of the immunologic status. The most frequently encountered lesions were cotton-wool patches, vascular congestion, hemorrhages, chorioretinitis, segmental vasculitis and optic disc pallar. Almost all the patients with ocular manifestations, also had a CD4 + count of less than 200/mm3 which suggest that ocular lesions are of bad prognostic significance even in asymptomatic patients.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/IMMUNOLOGY Adult Chorioretinitis/ETIOLOGY English Abstract Female Follow-Up Studies Human HIV Seropositivity/*COMPLICATIONS/IMMUNOLOGY Ischemia/ETIOLOGY Male Middle Age Retinal Diseases/*ETIOLOGY Retinal Hemorrhage/ETIOLOGY Retinal Vessels/PHYSIOPATHOLOGY JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/complications/immunologyadultchorioretinitis/etiologyenglishabstractfemalefollow-upstudieshumanhivseropositivity/KWDcomplications/immunologyischemia/etiologymalemiddleageretinaldiseases/KWDetiologyretinalhemorrhage/etiologyretinalvessels/physiopathologyjournalarticle
900830
M9080738

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .